产科抗磷脂抗体综合征临床观察的研究进展
Research Progress in Clinical Observation of Antiphospholipid Syndrome in Obstetrics
摘要: 抗磷脂抗体综合征(Antiphospholipid syndrome, APS)是一种实验室检查以抗磷脂抗体(antiphospholipid antibody, APL)持续阳性，临床标准以病态妊娠、血栓形成为主要特征的非炎性自身免疫性疾病。近年来，随着对APS的逐渐研究及认识的增加，临床上产科抗磷脂抗体综合征的患者越来越多见，APS孕妇的围产期的不良妊娠结局发生率也越来越高，早期且全程合理应用药物治疗可以有效改善妊娠结局及胎儿结局，所以APS患者的妊娠管理问题一直是风湿科和产科的难点和重点。由此可见，产科APS及其相关临床观察及母婴预后相关研究是临床研究者探讨的热点，下文就对目前研究进行详细阐述。
Abstract: Antiphospholipid syndrome (APS) is a noninflammatory autoimmune disorder characterized by persistently positive laboratory tests of antiphospholipid antibody (APL) and characterized by pathological pregnancy and thrombosis. In recent years, with the gradual research and increasing understanding of APS, there are more and more patients with obstetric antiphospholipid syndrome in clinical practice, and the incidence of adverse pregnancy outcomes in the perinatal period of APS pregnant women is also increasing. Rational application of drug therapy in the early and whole process can effectively improve pregnancy outcomes and fetal outcomes. Therefore, the pregnancy management of APS patients has always been the difficulty and focus of rheumatology and obstet-rics. It can be seen that obstetric APS and its related clinical observations and maternal and infant prognostic studies are hot topics discussed by clinical researchers. The current studies are elabo-rated in the following paragraphs.
文章引用：范洁, 王志梅. 产科抗磷脂抗体综合征临床观察的研究进展[J]. 临床医学进展, 2024, 14(3): 234-240. https://doi.org/10.12677/ACM.2024.143690

参考文献

[1] 抗磷脂综合征诊断和治疗指南[J]. 中华风湿病学杂志, 2011(6): 407-410.
[2] Tektonidou, M.G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., Costedoat-Chalumeau, N., Cuadrado, M.J., Dörner, T., Ferrer-Oliveras, R., Hambly, K., Khamashta, M.A., King, J., Marchiori, F., Meroni, P.L., Mosca, M., Pengo, V., Raio, L., Ruiz-Irastorza, G., Shoenfeld, Y., Stojanovich, L., Svenungsson, E., Wahl, D., Tincani, A. and Ward, M.M. (2019) EULAR Recommenda-tions for the Management of Antiphospholipid Syndrome in Adults. Annals of the Rheumatic Diseases, 78, 1296-1304. [Google Scholar] [CrossRef] [PubMed]
[3] Garcia, D. and Erkan, D. (2018) Diagnosis and Manage-ment of the Antiphospholipid Syndrome. The New England Journal of Medicine, 378, 2010-2021. [Google Scholar] [CrossRef] 
[4] Pires, D., Rosa, G., Bettencourt, P., Rodríguez-Pintó, I., Cervera, R. and Espinosa, G. (2020) “Non-Criteria” Antiphospholipid Syndrome: A Nomenclature Proposal. Autoimmunity Reviews, 19, Article ID: 102689. [Google Scholar] [CrossRef] [PubMed]
[5] Xourgia, E. and Tektonidou, M.G. (2022) An Update on An-tiphospholipid Syndrome. Current Rheumatology Reports, 23, Article No. 84. [Google Scholar] [CrossRef] [PubMed]
[6] Ambati, A., Knight, J.S. and Zuo, Y. (2023) Antiphospholipid Syndrome Management: A 2023 Update and Practical Algorithm-Based Approach. Current Opinion in Rheumatology, 35, 149-160. [Google Scholar] [CrossRef] 
[7] Walter, I.J., Klein Haneveld, M.J., Lely, A.T., Bloemen-kamp, K.W.M., Limper, M. and Kooiman, J. (2021) Pregnancy Outcome Predictors in Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis. Autoimmunity Reviews, 20, Article ID: 102901. [Google Scholar] [CrossRef] [PubMed]
[8] Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R.H., De Groot, P.G., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vla-choyiannopoulos, P.G. and Krilis, S.A. (2006) International Consensus Statement on an Update of the Classification Cri-teria for Definite Antiphospholipid Syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 295-306. [Google Scholar] [CrossRef] [PubMed]
[9] 孙笑丛, 马红玲, 赵娟. 凝血功能指标及抗磷脂抗体检测在妊娠合并抗磷脂综合征患者诊断中的价值[J]. 中国妇幼保健, 2019, 34(21): 4877-4880.
[10] Li, X., Deng, X., Duan, H., et al. (2021) Clinical Features Associated with Pregnancy Outcomes in Women with Positive Antiphospholip-id Antibodies and Previous Adverse Pregnancy Outcomes: A Real-World Prospective Study. Clinical Rheumatology, 40, 193-204. [Google Scholar] [CrossRef] [PubMed]
[11] Brandt, K.J., Fickentscher, C., Boehlen, F., Kruithof, E.K. and De Moerloose, P. (2014) NF-κB Is Activated from Endosomalcompartments in Antiphospholipid Antibod-ies-Treated Human Monocytes. Journal of Thrombosis and Haemostasis, 12, 779-791. [Google Scholar] [CrossRef] [PubMed]
[12] Sciascia, S., Amigo, M.C., Roccatello, D. and Khamashta, M. (2017) Diag-nosing Antiphospholipid Syndrome: “Extra-Criteria” Manifestations and Technical Advances. Nature Reviews Rheuma-tology, 13, 548-560. [Google Scholar] [CrossRef] [PubMed]
[13] Laurent, C., Ricard, L., Nguyen, Y., Boffa, J.J., Rondeau, E., Gerotziafas, G., Elalamy, I., Deriaz, S., De Moreuil, C., Planche, V., Johanet, C., Millot, F., Fain, O. and Mekinian, A. (2023) Triple Positive Profile in Antiphospholipid Syndrome: Prognosis, Relapse and Management from a Retrospective Multicentre Study. RMD Open, 9, e002534. [Google Scholar] [CrossRef] [PubMed]
[14] Simchen, M.J., Dulitzki, M., Rofe, G., Shani, H., Langevitz, P., Schiff, E. and Pauzner, R. (2011) High Positive Antibody Titers and Adverse Pregnancy Outcome in Women with An-tiphospholipid Syndrome. Acta Obstetricia et Gynecologica Scandinavica, 90, 1428-1433. [Google Scholar] [CrossRef] [PubMed]
[15] 郑晓娟, 邓晓莉, 刘湘源. 54例抗磷脂综合征患者的妊娠结局[J]. 北京大学学报(医学版), 2014, 46(2): 323-328.
[16] Tao, J.J., Adurty, S., D’Angelo, D. and De Sancho, M.T. (2023) Management and Outcomes of Women with Antiphospholipid Syndrome during Pregnancy. Journal of Thrombosis and Thrombolysis, 55, 751-759. [Google Scholar] [CrossRef] [PubMed]
[17] Rai, R., Cohen, H., Dave, M. and Regan, L. (1997) Randomised Controlled Trial of Aspirin and Aspirin plus Heparin in Pregnant Women with Recurrent Miscarriage Associated with Phospholipid Antibodies (or Antiphospholipid Antibodies). BMJ, 314, 253-257. [Google Scholar] [CrossRef] [PubMed]
[18] Empson, M., Lassere, M., Craig, J. and Scott, J. (2005) Prevention of Recurrent Miscarriage for Women with Antiphospholipid Antibody or Lupus Anticoagulant. Cochrane Database of Systematic Reviews, 2005, CD002859. [Google Scholar] [CrossRef] 
[19] Mak, A., Cheung, M.W., Cheak, A.A. and Ho, R.C. (2010) Combination of Heparin and Aspirin Is Superior to Aspirin Alone in Enhancing Live Births in Patients with Re-current Pregnancy Loss and Positive Anti-Phospholipid Antibodies: A Meta-Analysis of Randomized Controlled Trials and Meta-Regression. Rheumatology (Oxford), 49, 281-288. [Google Scholar] [CrossRef] [PubMed]
[20] Cervera, R., Piette, J.C., Font, J., Khamashta, M.A., Shoenfeld, Y., Camps, M.T., Jacobsen, S., Lakos, G., Tincani, A., Kontopoulou-Griva, I., Galeazzi, M., Meroni, P.L., Derksen, R.H., De Groot, P.G., Gromnica-Ihle, E., Baleva, M., Mosca, M., Bombardieri, S., Houssiau, F., Gris, J.C., Quéré, I., Hachulla, E., Vasconcelos, C., Roch, B., Fernández-Nebro, A., Boffa, M.C., Hughes, G.R., Ingelmo, M. and Eu-ro-Phospholipid Project Group (2002) Antiphospholipid Syndrome: Clinical and Immunologic Manifestations and Pat-terns of Disease Expression in a Cohort of 1,000 Patients. Arthritis & Rheumatology, 46, 1019-1027. [Google Scholar] [CrossRef] [PubMed]
[21] Rodger, M.A., Carrier, M., Le Gal, G., Martinelli, I., Perna, A., Rey, E., De Vries, J.I. and Gris, J.C. (2014) Meta-Analysis of Low-Molecular-Weight Heparin to Prevent Recurrent Placen-ta-Mediated Pregnancy Complications. Blood, 123, 822-828. [Google Scholar] [CrossRef] [PubMed]
[22] Committee on Practice Bulletins—Obstetrics, American Col-lege of Obstetricians and Gynecologists (2012) Practice Bulletin No. 132: Antiphospholipid Syndrome. Obstetrics & Gynecology, 120, 1514-1521. [Google Scholar] [CrossRef] 
[23] Urban, M.L., Bettiol, A., Mattioli, I., Emmi, G., Di Scala, G., Avagliano, L., Lombardi, N., Crescioli, G., Virgili, G., Serena, C., Mecacci, F., Ravaldi, C., Vannacci, A., Sil-vestri, E. and Prisco, D. (2021) Comparison of Treatments for the Prevention of Fetal Growth Restriction in Obstetric Antiphospholipid Syndrome: A Systematic Review and Network Meta-Analysis. Internal and Emergency Medicine, 16, 1357-1367. [Google Scholar] [CrossRef] [PubMed]
[24] Fredi, M., Andreoli, L., Aggogeri, E., Bettiga, E., Lazzaroni, M.G., Le Guern, V., Lojacono, A., Morel, N., Piette, J.C., Zatti, S., Costedoat-Chalumeau, N. and Tincani, A. (2018) Risk Factors for Adverse Maternal and Fetal Outcomes in Women with Confirmed APL Positivity: Results from a Multicenter Study of 283 Pregnancies. Frontiers in Immunology, 9, Article No. 864. [Google Scholar] [CrossRef] [PubMed]
[25] 吴庆军, 朱燕林, 唐福林. 抗磷脂综合征100例临床特征分析[J]. 中华风湿病学杂志, 2007, 11(11): 675-678.
[26] Rai, R.S., Regan, L., Clifford, K., Pickering, W., Dave, M., Mackie, I., McNally, T. and Cohen, H. (1995) Antiphospholipid Antibodies and Beta 2-Glycoprotein-I in 500 Women with Recurrent Miscarriage: Results of a Comprehensive Screening Approach. Human Reproduction, 10, 2001-2005. [Google Scholar] [CrossRef] [PubMed]
[27] Alijotas-Reig, J., Esteve-Valverde, E., Ferrer-Oliveras, R., LLurba, E., Ruffatti, A., Tincani, A., Lefkou, E., Bertero, M.T., Espinosa, G., De Carolis, S., Rovere-Querini, P., Lundelin, K., Picardo, E., Mekinian, A. and EUROAPS Study Group (2018) Comparative Study between Obstetric An-tiphospholipid Syndrome and Obstetric Morbidity Related with Antiphospholipid Antibodies. Medicina Clínica (Barc), 151, 215-222. [Google Scholar] [CrossRef] [PubMed]
[28] Mayer-Pickel, K., Tabacco, S., Arnau, A., TrapÉ, J., Ruiz-Hidalgo, D., Sos, L., Farran-Codina, I. and EUROAPS Study Group (2020) Comparative Study of Obstetric Antiphospholipid Syndrome (OAPS) and Non-Criteria Obstetric APS (NC-OAPS): Report of 1640 Cases from the EUROAPS Registry. Rheumatology (Oxford), 59, 1306-1314. [Google Scholar] [CrossRef] [PubMed]
[29] 陈玥, 王敬民, 李相君, 李晓东, 龙尚琴, 杨晓杰. 小剂量阿司匹林联合低分子肝素治疗时长对产科抗磷脂综合征妊娠结局的影响[J]. 中国实用妇科与产科杂志, 2022, 38(7): 739-742. [Google Scholar] [CrossRef] 

为你推荐